Conclusions: Understanding the molecular structure and function of STARD1 in all steroidogenic tissues is the key for comprehending the heterogeneous clinical manifestations of LCAH, and the development of an appropriate strategy for the induction of ovulation and protecting pregnancies in this disease. This evidence concerns the gene STAR and congenital lipoid adrenal hyperplasia due to STAR deficency.